Your browser doesn't support javascript.
loading
Toll-like Receptor 9 Agonists as Adjuvants for Nanoparticle-Based Nicotine Vaccine.
Hu, Yun; Smith, Daniel; Frazier, Evan; Zhao, Zongmin; Zhang, Chenming.
Affiliation
  • Hu Y; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
  • Smith D; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
  • Frazier E; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
  • Zhao Z; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
  • Zhang C; Department of Biological Systems Engineering, Virginia Tech, Blacksburg, Virginia 24061, United States.
Mol Pharm ; 18(3): 1293-1304, 2021 03 01.
Article in En | MEDLINE | ID: mdl-33497574
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Toll-Like Receptor 9 / Nanoparticles / Nicotine Limits: Animals Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / Toll-Like Receptor 9 / Nanoparticles / Nicotine Limits: Animals Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2021 Document type: Article Affiliation country: United States Country of publication: United States